Infectious disease specialists ask U.S. govt to ensure remdesivir supply - (Financial Post via NewsPoints Desk)

  • The Infectious Diseases Society of America (IDSA) asked the US government to “use every authority it has” to ensure adequate supplies of Gilead Sciences’ COVID-19 therapy remdesivir, as reported in the Financial Post.

  • In a letter to US Vice President Mike Pence and US Health and Human Services (HHS) Secretary Alex Azar, the group expressed concern that developed countries are relying on a single manufacturer to produce the antiviral.

  • “We urge the administration to fully leverage all authorities including the Defense Production Act and other tools to ensure adequate supplies of remdesivir,” the IDSA said.

  • Shortages of remdesivir, which the IDSA said has been critical for reducing the strain on hospitals, have been reported in several hard-hit states, prompting the HHS to ship emergency supplies to Florida, Texas, California and Arizona. 

  • “We are concerned that the current supply of remdesivir is insufficient, particularly given dramatically escalating caseloads in many states and the likelihood of a continuing surge into the fall and winter,” the letter said.

To read more NewsPoints articles, click here.